Showing results (1201-1210 of 2,492) with videos related to
Sort By:
Pageof 250
Expert Review of Vaccines|January 30, 2024
Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)Haruka Maeda, Nobuo Saito, Ataru Igarashi, et al.Expert Review of Vaccines|March 28, 2026
The impact of a pneumococcal vaccination on disease activity in children and adolescents with inflammatory bowel disease: a 2-year prospective studyMagdalena Neścioruk, Kinga Kowalska-Duplaga, Urszula Grzybowska-Chlebowczyk, et al.Expert Review of Vaccines|October 19, 2023
Immune response and safety of inactivated SARS-CoV-2 vaccines during pregnancy: a real-world observational studyYajie Gong, Xi Zhang, Xue Han, et al.Expert Review of Vaccines|October 26, 2023
Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in GermanyFelicitas Kühne, Katharina Achtert, Franziska Püschner, et al.Expert Review of Vaccines|October 17, 2023
Microarray patches: scratching the surface of vaccine deliveryJovin J Y Choo, Christopher L D McMillan, Paul R Young, et al.Expert Review of Vaccines|November 1, 2023
Public health impact and return on investment of the pediatric immunization program in PolandClaire E Mellott, Rafal Jaworski, Justin Carrico, et al.Expert Review of Vaccines|September 11, 2023
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United KingdomJames Campling, Andrew Vyse, Hui-Hsuan Liu, et al.Expert Review of Vaccines|April 22, 2026
Physician recommendation and vaccine hesitancy as key drivers of pneumococcal vaccination among older adults in China: a cross-sectional study using policy-stratified structural equation modelingYuxing Wang, Shuai Yuan, Xieyuan Ruo, et al.Expert Review of Vaccines|December 12, 2022
Insight into the current Toxoplasma gondii DNA vaccine: a review articleXirui Zhang, Hao Yuan, Yasser S Mahmmod, et al.Expert Review of Vaccines|October 24, 2023
Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adultsSophie Marbaix, Annick Mignon, Audrey Taelman, et al.Pageof 250